Occuity

Occuity is delighted to share that Dan Daly will be speaking at ScaleUp Britain in the South East on 16 April at the University of Surrey.

This event brings together founders, leaders, and ecosystem partners to explore one of the most important challenges for scaling businesses today — unlocking the right funding, at the right time, to support sustainable growth.

Dan will be joining a strong line-up of speakers to share insights, experiences, and practical perspectives on the funding landscape, opportunities for accessing capital in the current environment, and emerging funding solutions.

If you’re a founder or part of a scaling business in the South East, this is a great opportunity to:

• Gain practical insight into funding options
• Hear directly from investors and experts
• Connect with peers and the wider scaleup community

Find out more and register here: https://zurl.co/q3u9Q

We’ve just published a short write-up about our experience at 100% Optical this weekend and it’s safe to say the momentum around AX1 is building.

The level of interest in the device from academia, independents and large groups was remarkable. What stood out most was how quickly optometrists were able to pick up the AX1 and start measuring axial length. In many cases, people were taking repeatable measurements within seconds of using the device for the first time.

That ease of use really matters.

Over the last few years there has been a clear shift in optometry. Myopia management is no longer something discussed occasionally - it’s increasingly recognised as part of a practitioner’s duty of care. Many more ECPs are now offering spectacle and contact lens solutions than ever before.

But many are still doing this without measuring axial length.

We heard the same challenges repeatedly:

• Existing systems are expensive
• Desktop devices take up valuable practice space
• Equipment gets tied up in testing rooms

So the idea of a handheld, fast, easy-to-use axial length device that fits into everyday workflows clearly resonated.

We also had some fun running the AX1 Scan Challenge at the stand. We found axial lengths ranging from 20.85 mm to 29.5 mm, and the fastest person scanned both of my (very long!) eyes in just 45 seconds — within minutes of picking up the device.

It really does feel like an exciting time for Occuity.

You can read the full recap here:
https://zurl.co/JCyiy

And if you missed us at the show but want to register interest in AX1, you can do that here:
https://zurl.co/BAIPB

100% Optical 2026: Momentum Builds for AX1 This weekend Occuity was delighted to attend the UK's largest Optical tradeshow - 100% Optical - with our UK Distributor, Birmingham Optical. And I have to say, the level of interest in Occuity’s technology was striking.

If you’re heading to 100% Optical this weekend, it’s well worth stopping by to see Occuity on Birmingham Optical - The Optical Company - Stand L30!

We’re running the AX1 Speed Scan Challenge, giving visitors the chance to experience fast, non-contact axial length measurement and see just how intuitive the AX1 is in real clinical hands. No Chin rests. No contact. Just a quick scan and clear data.

Axial length is becoming central to how we think about myopia management and long-term eye health. If you’re curious about axial length, myopia control, or where ocular biometry is heading next, come and have a go. Sometimes the best way to understand new technology is simply to sit down and try it.

See you at 100% Optical.

🚀 We’re bringing the AX1 to 100% Optical - and we're inviting you to take part in the "AX1 Speed Scan Challenge".

Visit us on stand L30 with Birmingham Optical.

✔ Try the AX1
✔ 3 x £1,000 cashback Prizes to be won*
✔ Get priority access on release

Over the weekend we passed our £1.1 million target on Republic and welcomed our 300th investor into the Occuity community. Thank you to everyone who has supported the campaign so far.

Hitting our target triggered the official 7 day countdown. This means the round will officially close at 12midnight on Friday 19th December. Once this window closes, the round will end.

If you’ve been following our progress and are considering joining us, now is the moment. With momentum building, major milestones achieved in the lab, and strong interest in our PM1, AX1 and Oculomics roadmap, we believe the future for Occuity has never looked more exciting. As the next round is very likely to be an institutional Series A raise, this will be your last chance to invest in Occuity.

Five days to go. Don’t miss your chance to be part of what comes next.
https://zurl.co/ieqmb